Analysis of segregation patterns in Machado-Joseph disease pedigrees
- PMID: 18688568
- DOI: 10.1007/s10038-008-0330-y
Analysis of segregation patterns in Machado-Joseph disease pedigrees
Abstract
Machado-Joseph disease (MJD), also known as spinocerebellar ataxia type 3 (SCA3), is an autosomal dominant neurodegenerative disorder of late onset, which is considered the most common form of SCA worldwide. The main goal of this study was to investigate the presence of segregation ratio distortion (SRD) during transmissions of ATXN3 alleles by MJD patients, evaluating the putative role of SRD in the epidemiological representation of the disease. Sixty-two complete sibships, each with one clinically affected parent, totalling 330 transmissions were selected according to defined criteria and used for segregation analysis. Onset data from MJD patients with Azorean origin was used for residual risk estimates according to different ages. Residual risk values were applied to unaffected offspring to calculate the probability of inheriting the expanded allele. The proportion of offspring that received the expanded or the normal allele from the affected parent was calculated to determine the presence of SRD during transmissions of ATXN3 alleles by MJD patients. Segregation of ATXN3 alleles was in accordance with the expected Mendelian proportions (chi (2) = 0.982, P = 0.322). However, there was a tendency favouring the transmission of the normal alleles. Thus, SRD is not a potential mechanism on the basis of MJD epidemiological representation.
Similar articles
-
Spinocerebellar ataxia type 3/Machado-Joseph disease: segregation patterns and factors influencing instability of expanded CAG transmissions.Clin Genet. 2016 Aug;90(2):134-40. doi: 10.1111/cge.12719. Epub 2016 Feb 3. Clin Genet. 2016. PMID: 26693702
-
Parkinsonian phenotype in Machado-Joseph disease (MJD/SCA3): a two-case report.BMC Neurol. 2011 Oct 24;11:131. doi: 10.1186/1471-2377-11-131. BMC Neurol. 2011. PMID: 22023810 Free PMC article.
-
APOE ε2 allele may decrease the age at onset in patients with spinocerebellar ataxia type 3 or Machado-Joseph disease from the Chinese Han population.Neurobiol Aging. 2014 Sep;35(9):2179.e15-8. doi: 10.1016/j.neurobiolaging.2014.03.020. Epub 2014 Mar 22. Neurobiol Aging. 2014. PMID: 24746364
-
Selective forces acting on spinocerebellar ataxia type 3/Machado-Joseph disease recurrency: A systematic review and meta-analysis.Clin Genet. 2021 Mar;99(3):347-358. doi: 10.1111/cge.13888. Epub 2020 Dec 2. Clin Genet. 2021. PMID: 33219521
-
Machado-Joseph disease/spinocerebellar ataxia type 3.Handb Clin Neurol. 2012;103:437-49. doi: 10.1016/B978-0-444-51892-7.00027-9. Handb Clin Neurol. 2012. PMID: 21827905 Free PMC article. Review.
Cited by
-
Sodium valproate increases activity of the sirtuin pathway resulting in beneficial effects for spinocerebellar ataxia-3 in vivo.Mol Brain. 2021 Aug 20;14(1):128. doi: 10.1186/s13041-021-00839-x. Mol Brain. 2021. PMID: 34416891 Free PMC article.
-
Altered Metabolic Signaling and Potential Therapies in Polyglutamine Diseases.Metabolites. 2024 May 31;14(6):320. doi: 10.3390/metabo14060320. Metabolites. 2024. PMID: 38921455 Free PMC article. Review.
-
Psychological well-being and family satisfaction levels five years after being confirmed as a carrier of the Machado-Joseph disease mutation.Genet Test Mol Biomarkers. 2012 Dec;16(12):1363-8. doi: 10.1089/gtmb.2011.0370. Genet Test Mol Biomarkers. 2012. PMID: 23153003 Free PMC article.
-
The Homogeneous Azorean Machado-Joseph Disease Cohort: Characterization and Contributions to Advances in Research.Biomedicines. 2023 Jan 18;11(2):247. doi: 10.3390/biomedicines11020247. Biomedicines. 2023. PMID: 36830784 Free PMC article. Review.
-
Population genetics and new insight into range of CAG repeats of spinocerebellar ataxia type 3 in the Han Chinese population.PLoS One. 2015 Aug 12;10(8):e0134405. doi: 10.1371/journal.pone.0134405. eCollection 2015. PLoS One. 2015. PMID: 26266536 Free PMC article.